Search results
Results from the WOW.Com Content Network
Guidelines on the choice of agents and how best to step up treatment for various subgroups in hypertension (high blood pressure) have changed over time and differ between countries. A Comparison of International Guidelines on Goal Blood Pressure and Initial Therapy for Adults With Hypertension (adapted from JNC 8 guidelines [ 1 ] )
Guidelines for treating resistant hypertension have been published in the UK [45] and US. [46] It has been proposed that a proportion of resistant hypertension may be the result of chronic high activity of the autonomic nervous system, known as "neurogenic hypertension". [47] Low adherence to treatment is an important cause of resistant ...
Hypertension or high blood pressure affects at least 26.4% of the world's population. [15] Hypertensive heart disease is only one of several diseases attributable to high blood pressure . Other diseases caused by high blood pressure include ischemic heart disease , cancer , stroke , peripheral arterial disease , aneurysms and kidney disease .
The major indication for pharmacologic antihypertensive therapy is progression to hypertension. The threshold is lower in patients with diabetes, chronic kidney failure, or cardiovascular disease. [17] The target blood pressure for these conditions is currently less than 120/80 mm Hg.
A more recent 2024 study — also funded by Novo Nordisk — is currently the longest clinical trial on semaglutide for weight loss. It looked at almost 18,000 participants with excess weight or ...
New York’s new toll for drivers entering the center of Manhattan debuted Sunday, meaning many people will pay $9 to access the busiest part of the Big Apple during peak hours.
Fewer fans appeared to attend the postponed Sugar Bowl between Notre Dame and Georgia on Thursday in light of the terror attack in New Orleans.
This is because they have been associated with increased risk of new-onset diabetes and as such are recommended for use in patients over 65, for whom the risk of new-onset diabetes is outweighed by the benefits of controlling systolic blood pressure. [8] Another theory is that they are off-patent and thus rarely promoted by the drug industry. [9]